Brand
Boehringer Ingelheim Pharmaceuticals, Inc.
2 federal recalls on file, showing the 1 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for Boehringer Ingelheim Pharmaceuticals, Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-07-08FDA-DrugClass IISynjardy XR tablets recalled for manufacturing deviation
Boehringer Ingelheim Pharmaceuticals is recalling one lot of Synjardy XR 12.5/1000 mg tablets due to manufacturing quality control issues. During production, an incorrect cleaning agent was used on equipment, and required testing of that equipment was not completed before the tablets were made.
Get notified about new Boehringer Ingelheim Pharmaceuticals, Inc. recalls
Free weekly digest. We email when a new federal recall affects Boehringer Ingelheim Pharmaceuticals, Inc. or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state
Get alerts for your household